{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:06:20Z","timestamp":1782273980068,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T00:00:00Z","timestamp":1518393600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s40261-018-0627-3","type":"journal-article","created":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T07:52:25Z","timestamp":1518421945000},"page":"457-462","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Differences in Metabolic Factors Between Antipsychotic-Induced Weight Gain and Non-pharmacological Obesity\u00a0in Youths"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5704-4483","authenticated-orcid":false,"given":"Simone","family":"Pisano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giangennaro","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Catone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Carotenuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Iuliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"D\u2019Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Cabaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Miraglia del Giudice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Bravaccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Formisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,12]]},"reference":[{"key":"627_CR1","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1001\/jamapsychiatry.2015.0500","volume":"72","author":"M Olfson","year":"2015","unstructured":"Olfson M, King M, Schoenbaum M. Treatment of young people with antipsychotic medications in the United States. JAMA Psychiatry. 2015;72:867\u201374.","journal-title":"JAMA Psychiatry"},{"key":"627_CR2","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00228-015-1982-0","volume":"72","author":"M Pozzi","year":"2016","unstructured":"Pozzi M, Cattaneo D, Baldelli S, Fucile S, Capuano A, Bravaccio C, Sportiello L, Bertella S, Auricchio F, Bernardini R, Ferrajolo C, Guastella G, Mani E, Carnovale C, Pisano S, Rafaniello C, Riccio MP, Rizzo R, Scuderi MG, Sperandeo S, Villa L, Pascotto A, Molteni M, Rossi F, Radice S, Clementi E. Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: an observational study in real-life settings. Eur J Clin Pharmacol. 2016;72:285\u201393.","journal-title":"Eur J Clin Pharmacol"},{"key":"627_CR3","doi-asserted-by":"publisher","first-page":"e1601","DOI":"10.4088\/JCP.15m10247","volume":"77","author":"M Pozzi","year":"2016","unstructured":"Pozzi M, Pisano S, Bertella S, Capuano A, Rizzo R, Antoniazzi S, Auricchio F, Carnovale C, Cattaneo D, Ferrajolo C, Gentili M, Guastella G, Mani E, Rafaniello C, Riccio MP, Scuderi MG, Sperandeo S, Sportiello L, Villa L, Radice S, Clementi E, Rossi F, Pascotto A, Bernardini R, Molteni M, Bravaccio C. Persistence in therapy with risperidone and aripiprazole in pediatric outpatients: a 2-year naturalistic comparison. J Clin Psychiatry. 2016;77:e1601\u20139.","journal-title":"J Clin Psychiatry"},{"key":"627_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14740338.2016.1229301","volume":"15","author":"C Rafaniello","year":"2016","unstructured":"Rafaniello C, Pozzi M, Pisano S, Ferrajolo C, Bertella S, Sportiello L, Carnovale C, Sullo MG, Cattaneo D, Gentili M, Rizzo R, Pascotto A, Mani E, Villa L, Riccio MP, Sperandeo S, Bernardini R, Bravaccio C, Clementi E, Molteni M, Rossi F, Radice S, Capuano A. Second generation antipsychotics in \u2018real-life\u2019 paediatric patients: adverse drug reactions and clinical outcomes of drug switch. Expert Opin Drug Saf. 2016;15:1\u20138.","journal-title":"Expert Opin Drug Saf"},{"key":"627_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1089\/cap.2010.0020","volume":"22","author":"LA Kryzhanovskaya","year":"2012","unstructured":"Kryzhanovskaya LA, Xu W, Millen BA, Acharya N, Jen KY, Osuntokun O. Comparison of long-term (at least 24\u00a0weeks) weight gain and metabolic changes between adolescents and adults treated with olanzapine. J Child Adolesc Psychopharmacol. 2012;22:157\u201365.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"627_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13052-016-0259-2","volume":"42","author":"S Pisano","year":"2016","unstructured":"Pisano S, Catone G, Veltri S, Lanzara V, Pozzi M, Clementi E, Iuliano R, Riccio MP, Radice S, Molteni M, Capuano A, Gritti A, Coppola G, Milone A, Bravaccio C, Masi G. Update on the safety of second generation antipsychotics in youths: a call for collaboration among paediatricians and child psychiatrists. Ital J Pediatr. 2016;42:51\u201361.","journal-title":"Ital J Pediatr"},{"key":"627_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1089\/cap.2012.0060","volume":"23","author":"S Pisano","year":"2013","unstructured":"Pisano S, Gritti A, Catone G, Pascotto A. Antipsychotic-induced dyslipidemia treated with omega 3 fatty acid supplement in an 11-year-old psychotic child: a 1-year follow-up. J Child Adolesc Psychopharmacol. 2013;23:139\u201341.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"627_CR8","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1001\/jama.2009.1549","volume":"302","author":"CU Correll","year":"2009","unstructured":"Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA. 2009;302:1765\u201373.","journal-title":"JAMA"},{"key":"627_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1001\/jamapsychiatry.2015.2923","volume":"73","author":"B Galling","year":"2016","unstructured":"Galling B, Rold\u00e1n A, Nielsen RE, Nielsen J, Gerhard T, Carbon M, Stubbs B, Vancampfort D, De Hert M, Olfson M, Kahl KG, Martin A, Guo JJ, Lane HY, Sung FC, Liao CH, Arango C, Correll CU. Type 2 diabetes mellitus in youth exposed to antipsychotics: a systematic review and meta-analysis. JAMA Psychiatry. 2016;73:247\u201359.","journal-title":"JAMA Psychiatry"},{"key":"627_CR10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.schres.2007.11.026","volume":"100","author":"H Jin","year":"2008","unstructured":"Jin H, Meyer JM, Mudaliar S, Jeste DV. Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin. Schizophr Res. 2008;100:70\u201385.","journal-title":"Schizophr Res"},{"key":"627_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.psyneuen.2015.03.012","volume":"56","author":"F Bartoli","year":"2015","unstructured":"Bartoli F, Lax A, Crocamo C, Clerici M, Carr\u00e0 G. Plasma adiponectin levels in schizophrenia and role of second-generation antipsychotics: a meta-analysis. Psychoneuroendocrinology. 2015;56:179\u201389.","journal-title":"Psychoneuroendocrinology"},{"key":"627_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00787-016-0866-x","volume":"26","author":"I Baeza","year":"2017","unstructured":"Baeza I, Vigo L, de la Serna E, Calvo-Escalona R, Merch\u00e1n-Naranjo J, Rodr\u00edguez-Latorre P, Arango C, Castro-Fornieles J. The effects of antipsychotics on weight gain, weight-related hormones and homocysteine in children and adolescents: a 1-year follow-up study. Eur Child Adolesc Psychiatry. 2017;26:35\u201346.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"627_CR13","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1089\/cap.2016.0203","volume":"27","author":"S Pisano","year":"2017","unstructured":"Pisano S, Catone G, Coppola G, Carotenuto M, Iuliano R, Tiano C, Montesanto AR, D\u2019Esposito V, Del Giudice EM, Formisano P, Bravaccio C. Different immune signature in youths experiencing antipsychotic-induced weight gain compared to untreated obese patients. J Child Adolesc Psychopharmacol. 2017;27:844\u20138.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"627_CR14","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1111\/obr.12561","volume":"18","author":"O Ajala","year":"2017","unstructured":"Ajala O, Mold F, Boughton C, Cooke D, Whyte M. Childhood predictors of cardiovascular disease in adulthood: a systematic review and meta-analysis. Obes Rev. 2017;18:1061\u201370.","journal-title":"Obes Rev"},{"key":"627_CR15","doi-asserted-by":"publisher","first-page":"899","DOI":"10.4088\/JCP.13m08820","volume":"75","author":"BH Ebdrup","year":"2014","unstructured":"Ebdrup BH, Knop FK, Madsen A, Mortensen HB, S\u00f8gaard B, Holst JJ, Szecsi PB, Lublin H. Glucometabolic hormones and cardiovascular risk markers in antipsychotic-treated patients. J Clin Psychiatry. 2014;75:899\u2013905.","journal-title":"J Clin Psychiatry"},{"key":"627_CR16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/bs.ircmb.2016.05.002","volume":"326","author":"R Sekar","year":"2016","unstructured":"Sekar R, Singh K, Arokiaraj AW, Chow BK. Pharmacological actions of glucagon-like peptide-1, gastric inhibitory polypeptide, and glucagon. Int Rev Cell Mol Biol. 2016;326:279\u2013341.","journal-title":"Int Rev Cell Mol Biol"},{"key":"627_CR17","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s13300-017-0265-4","volume":"8","author":"E Leighton","year":"2017","unstructured":"Leighton E, Sainsbury CA, Jones GC. A practical review of C-peptide testing in diabetes. Diabetes Ther. 2017;8:475\u201387.","journal-title":"Diabetes Ther"},{"key":"627_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cell.2014.06.005","volume":"158","author":"JC Lo","year":"2014","unstructured":"Lo JC, Ljubicic S, Leibiger B, Kern M, Leibiger IB, Moede T, Kelly ME, Chatterjee Bhowmick D, Murano I, Cohen P, Banks AS, Khandekar MJ, Dietrich A, Flier JS, Cinti S, Bl\u00fcher M, Danial NN, Berggren PO, Spiegelman BM. Adipsin is an adipokine that improves \u03b2 cell function in diabetes. Cell. 2014;158:41\u201353.","journal-title":"Cell"},{"key":"627_CR19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5507\/bp.2017.002","volume":"161","author":"A Smekal","year":"2017","unstructured":"Smekal A, Vaclavik J. Adipokines and cardiovascular disease: a comprehensive review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017;161:31\u201340.","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"627_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/eip.12457","author":"R Bal\u00f5t\u0161ev","year":"2017","unstructured":"Bal\u00f5t\u0161ev R, Haring L, Koido K, Leping V, Kriisa K, Zilmer M, Vasar V, Piir A, Lang A, Vasar E. Antipsychotic treatment is associated with inflammatory and metabolic biomarkers alterations among first-episode psychosis patients: a 7-month follow-up study. Early Interv Psychiatry. 2017. \n                    https:\/\/doi.org\/10.1111\/eip.12457\n                    \n                   (Epub ahead of print).","journal-title":"Early Interv Psychiatry"},{"key":"627_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000441521","volume":"2","author":"TM Fonseka","year":"2016","unstructured":"Fonseka TM, M\u00fcller DJ, Kennedy SH. Inflammatory cytokines and antipsychotic-induced weight gain: review and clinical implications. Mol Neuropsychiatry. 2016;2:1\u201314.","journal-title":"Mol Neuropsychiatry"},{"key":"627_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/00131746-200507000-00004","volume":"11","author":"F Centorrino","year":"2005","unstructured":"Centorrino F, Fogarty KV, Cimbolli P, Salvatore P, Thompson TA, Sani G, Cincotta SL, Baldessarini RJ. Aripiprazole: initial clinical experience with 142 hospitalized psychiatric patients. J Psychiatr Pract. 2005;11:241\u20137.","journal-title":"J Psychiatr Pract"},{"key":"627_CR23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s40272-015-0119-3","volume":"17","author":"G Masi","year":"2015","unstructured":"Masi G, Milone A, Veltri S, Iuliano R, Pfanner C, Pisano S. Use of quetiapine in children and adolescents. Paediatr Drugs. 2015;17:125\u201340.","journal-title":"Paediatr Drugs"},{"key":"627_CR24","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/JCP.0000000000000371","volume":"35","author":"G Masi","year":"2015","unstructured":"Masi G, Milone A, Stawinoga A, Veltri S, Pisano S. Efficacy and safety of risperidone and quetiapine in adolescents with bipolar II disorder comorbid with conduct disorder. J Clin Psychopharmacol. 2015;35:587\u201390.","journal-title":"J Clin Psychopharmacol"},{"key":"627_CR25","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/MPG.0b013e318284abb5","volume":"56","author":"P Vajro","year":"2013","unstructured":"Vajro P, Paolella G, Fasano A. Microbiota and gut-liver axis: their influences on obesity and obesity-related liver disease. J Pediatr Gastroenterol Nutr. 2013;56:461\u20138.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"627_CR26","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3389\/fnins.2017.00490","volume":"11","author":"JR Kelly","year":"2017","unstructured":"Kelly JR, Minuto C, Cryan JF, Clarke G, Dinan TG. Cross talk: the microbiota and neurodevelopmental disorders. Front Neurosci. 2017;11:490.","journal-title":"Front Neurosci"},{"key":"627_CR27","doi-asserted-by":"publisher","first-page":"e652","DOI":"10.1038\/tp.2015.135","volume":"5","author":"SM Bahr","year":"2015","unstructured":"Bahr SM, Tyler BC, Wooldridge N, Butcher BD, Burns TL, Teesch LM, Oltman CL, Azcarate-Peril MA, Kirby JR, Calarge CA. Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children. Transl Psychiatry. 2015;5:e652.","journal-title":"Transl Psychiatry"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-018-0627-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-018-0627-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-018-0627-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T19:33:05Z","timestamp":1549913585000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-018-0627-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,12]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["627"],"URL":"https:\/\/doi.org\/10.1007\/s40261-018-0627-3","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,12]]},"assertion":[{"value":"12 February 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Simone Pisano, Giangennaro Coppola, Gennaro Catone, Marco Carotenuto, Raffaella Iuliano, Vittoria D\u2019Esposito, Serena Cabaro, Emanuele Miraglia del Giudice, Carmela Bravaccio, and Pietro Formisano have no conflicts of interest directly relevant to the content of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Institutional Review Board of the University of Campania approved the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All caregivers and patients received a thorough explanation of the purpose of the study and were asked if they were willing to participate; caregivers signed the consent form.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}